title: Challenging cases and diagnostic dilemmas: case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease.
authors.affiliation: Institute of Nuclear Medicine and Meyerstein Institute of Oncology, Middlesex Hospital, London, United Kingdom.
authors.forename: J B
authors.initials: JB
authors.lastname: Bomanji
authors.forename: R
authors.initials: R
authors.lastname: Syed
authors.forename: C
authors.initials: C
authors.lastname: Brock
authors.forename: P
authors.initials: P
authors.lastname: Jankowska
authors.forename: A
authors.initials: A
authors.lastname: Dogan
authors.forename: D C
authors.initials: DC
authors.lastname: Costa
authors.forename: P J
authors.initials: PJ
authors.lastname: Ell
authors.forename: S M
authors.initials: SM
authors.lastname: Lee
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D019788:Fluorodeoxyglucose F18; D006099:Granuloma / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008477:Mediastinal Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy; D014055:Tomography, Emission-Computed
chemical_list: D019788:Fluorodeoxyglucose F18